Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,367 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Completed

Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab

NCT03674567

Conditions
Advanced Cancer, Breast Diseases, Breast Neoplasms, +44 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles JCCC Clinical Research Unit Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 35 locations
View Trial Details
Completed

Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT04815720

Conditions
Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +12 more
Locations
  • Highlands Oncology Group, PA - North Hills Springdale, Arkansas, United States
  • California Cancer Associates for Research and Excellence (CCARE)-Fresno Fresno, California, United States
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 15 locations
View Trial Details
Completed

De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study

NCT02281955

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +12 more
Locations
  • University of Florida Gainesville, Florida, United States
  • University of North Carolina at Chapel Hill, Department of Radiation Oncology Chapel Hill, North Carolina, United States
  • Pardee Memorial Hospital Hendersonville, North Carolina, United States
  • High Point Regional Health High Point, North Carolina, United States
View Trial Details
Completed

Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)

NCT02573493

Conditions
Cancer of Head and Neck, Cancer of the Head and Neck, Carcinoma, +11 more
Locations
  • The University of Kansas Cancer Center and Medical Pavilion Westwood, Kansas, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Sanford Cancer Center Sioux Falls, South Dakota, United States
View Trial Details
Completed

A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

NCT03997968

Conditions
Adnexal Diseases, Blood Protein Disorders, Breast Cancer, +68 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Stanford Comprehensive Cancer Center Stanford, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
View all 16 locations
View Trial Details

Related conditions